Organogenesis buys materials firm NanoMatrix
Organogenesis Inc., a life sciences firm focused on regenerative medicine, has acquired a maker of biologically compatible materials called NanoMatrix Inc.
Organogenesis, based in Canton, said the buyout enhances its spot as a leading producer of three-dimensional regenerative medicine products. Terms of the deal between the privately held firms were not disclosed.
NanoMatrix, of Baton Rouge, La., has expertise in a process called electrospinning, which enables the assembly of tiny fibers into three-dimensional scaffolds, intended to mimic the structure and biochemical environment of human tissue, according to Organogenesis freecreditreport.
Organogenesis makes a living-cell tissue product called Apligraf used as a skin substitute. The firm employs about 300 people and reported 2007 revenue of $55 million.